Your browser doesn't support javascript.
loading
Joint modeling of progression-free and overall survival and computation of correlation measures.
Meller, Matthias; Beyersmann, Jan; Rufibach, Kaspar.
Afiliação
  • Meller M; Department of Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Beyersmann J; Institute of Statistics, Ulm University, Ulm, Germany.
  • Rufibach K; Department of Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Stat Med ; 38(22): 4270-4289, 2019 09 30.
Article em En | MEDLINE | ID: mdl-31273817
In this paper, we derive the joint distribution of progression-free and overall survival as a function of transition probabilities in a multistate model. No assumptions on copulae or latent event times are needed and the model is allowed to be non-Markov. From the joint distribution, statistics of interest can then be computed. As an example, we provide closed formulas and statistical inference for Pearson's correlation coefficient between progression-free and overall survival in a parametric framework. The example is inspired by recent approaches to quantify the dependence between progression-free survival, a common primary outcome in Phase 3 trials in oncology and overall survival. We complement these approaches by providing methods of statistical inference while at the same time working within a much more parsimonious modeling framework. Our approach is completely general and can be applied to other measures of dependence. We also discuss extensions to nonparametric inference. Our analytical results are illustrated using a large randomized clinical trial in breast cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Modelos Estatísticos / Intervalo Livre de Doença / Intervalo Livre de Progressão Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Modelos Estatísticos / Intervalo Livre de Doença / Intervalo Livre de Progressão Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article